期刊文献+

层析法去除A群流脑多糖疫苗粗糖中杂蛋白 被引量:10

A Chromotography Method for Removing Impurity Proteins from Meningococcal Polysaccharide Type A Sample
原文传递
导出
摘要 目的:建立用层析法去除脑脊髓膜炎球菌A群荚膜多糖样品中的杂蛋白的方法,以替代传统的苯酚抽提。方法:A群流脑多糖粗糖经过新型多模式离子交换填料Capto adhere,使用低盐上样高盐洗脱,洗脱的目的峰再经过Sephardex G-25凝胶过滤脱盐换成水,即为流脑多糖精糖原液。结果:采用上述方法制备的精制多糖样品中杂蛋白占固总的比例低于0.2%,符合WHO现行规程中的杂蛋白比例低于1%的要求,核酸、内毒素等生化指标均符合现行规程,整个层析过程的回收率大于65%。结论:层析法去除A群流脑多糖粗糖中的杂蛋白是有效的,比传统的苯酚抽提的方法更有利于环保,易于操作,易于放大。 Objective:Set a new chromatography method to remove impurity proteins from meningococcal polysaccharide type A sample instead of the traditional phenol abstraction method. Method:This new method includes two purification steps by using Capto adhere and Sephardex G-25. Result:The contaminative protein concentration is 0.2% in final meningococcal polysaccharise type A sample, which is below the WHO regulation standard ( 1% ), the content of nucleic acid and endotoxin are also blow the current regulation standard, the recovery is over 65%. Conclusion:Compare with the tradition phenol abstraction method, the chromatography method can remove impurity proteins effectively with high recovery and reducing environment pollution and easy to scale up.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第8期88-92,共5页 China Biotechnology
关键词 流行性脑脊髓膜炎 层析法 Capto adhere Meningococcal meningitis Chromatography Capto ashere
  • 相关文献

参考文献4

  • 1赵凯.医学生物制品学.第2版.北京:人民卫生出版社,2007.10:511.
  • 2Tania Pinheiro Pato , Antonio de P' adua R. Barbosa, Jos'e Godinho da Silva Junior . Purification of capsular polysaccharide from Neisseria meningitides serogrou PC by liquid chromatography. Journal of Chromatography B, 2006,832:262-267.
  • 3Protein purification : principles, high resolution methods, and application. Jan-christer Janson, Lars Ryden.-2^nd ed. 145-200.
  • 4Lars Hangel, Gunter jagschies, Gail sofer. Handbook of Process Chromatography, Development, Manufacturing, Validation and Economics. 2^nd ed. 237-298.

同被引文献54

  • 1焦洋,黄平,唐青,罗凤基.狂犬病病毒糖蛋白的性质及其应用[J].慢性病学杂志,2013,13(8):600-604. 被引量:8
  • 2严群芳.非离子表面活性剂的性质及应用[J].贵州化工,2005,30(5):4-7. 被引量:41
  • 3李建平,杨屹,王宇,李德娟,陈万革.纯化乙型肝炎病毒表面抗原新层析工艺的建立[J].中国生物制品学杂志,2006,19(6):641-643. 被引量:3
  • 4杨明,陈作江,曹鑫,王志军,崔萱林.C群脑膜炎球菌多糖纯化方法的改进[J].微生物学免疫学进展,2006,34(4):27-29. 被引量:4
  • 5WHO. Typhoid vaccines: WHO position paper [J]. Wkly Epid-emiolRec, 2008, 83 (6): 49-59.
  • 6Khan MI, Ochiai RL, Clemens JD. Population impact of Vi caps- ular polysaccharide vaccine EJ. Expe Rev Vaccines, 2010, 9 (5): 485-496.
  • 7Schwartz E. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India [J]. N Engl J Med, 2009, 361 (22): 2191-2192.
  • 8Kothari S, Kothari N, Lee E, et al. Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide [J]. Procedia Vaccinol, 2010, 2 (1): 78- 81.
  • 9Hamidi A, Beurret MF. Process for producing a capsular polysac- charide for use in conjugate vaccines [P]: USA, US Patent App- lication 20070065460, 2007-03-22.
  • 10Pato TP, Barbosa Ade P, Da Silva Junior JG. Purification of capsular polysaccharide from Neisseria meningitidis serogroup C by liquid chromatography [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2006, 832(2): 262-267.

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部